New thinking on how pharma can help drive better patient medication adherence Non-adherence to medication is bad news—and it’s proving a tough nut to crack. For pharma, it can mean a loss of revenue, negative perceptions about the real-world efficacy of a drug and even undermine the prospects of products conditionally approved based on real-world outcomes. So, what role can pharma play in really changing patient behaviour? How is digital innovation and data analytics driving new approaches and improving outcomes? In this report, experts explore the technologies shaping patient support programme development.
Companies
Otsuka Pharmaceutical, Oracle
Subject synopsis
Research methodology and objectives
Key insights summary
Issues and insights
The impact of medication non-adherence
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Addressing medication non-adherence
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Advances in medication adherence programmes and technologies
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
The future role of technology and data in medication adherence
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibit
Ensuring successful innovation in medication adherence